The inadequate corpus luteum.
Level 5 - mechanism / opinion, no new human data
Narrative commentary and expert opinion with no primary human data or systematic review methodology.
PubMed 35128435 · doi:10.1530/RAF-20-0044
What was done
This commentary reviewed the physiology of the corpus luteum, the concept of corpus luteum inadequacy, and the evidence supporting exogenous progesterone supplementation in fertility treatments and early pregnancy.
What was found
No quantitative data or statistics were reported in the abstract. The author notes that progesterone is necessary during IVF cycles and benefits women presenting with bleeding in early pregnancy who have a history of miscarriages, but emphasizes there is no evidence that unselected recurrent or threatened miscarriage is caused by inadequate corpus luteum function or progesterone deficiency.
Why it matters
It cautions clinicians against uncritical, off-label progesterone supplementation for assumed luteal phase defects, balancing clinical benefit against potential unknown effects of altered hormonal environments during early development.
Limits
This is a narrative commentary without original clinical trial data, systematic literature search methodology, or quantitative risk-benefit estimates. The abstract does not define diagnostic criteria or measurement thresholds for corpus luteum insufficiency.
Cited by
- supports During the first 12 weeks of pregnancy, the corpus luteum releases progesterone to support endometrial implantation and maintain early pregnancy.